BioFrontier Partners, Inc.


BioFrontier Partners, Inc. is a leading Japanese company that supports businesses related to bio and life sciences. The company is involved in venture capital activities and life science support services, aiming to foster innovation and growth in these sectors.

BioFrontier Partners, Inc.

BioFrontier Partners, Inc.

Kitano Building 3rd FL, 2-6-11 Chuo-ku, Nihonbashi-kayabacho, Tokyo, Japan 103-0025


What We Do

BioFrontier Partners provides venture capital services, including fund management and investment in bio and healthcare-related companies in Japan and internationally. They focus on identifying promising ventures and providing the necessary capital and support for growth.

The company offers consulting and research services in the life sciences sector, helping clients navigate challenges and develop strategies for new business development, product development, and market entry. They leverage extensive networks and expertise to provide tailored solutions.


Investment Stage


Portfolio

Listed on the Tokyo Stock Exchange Mothers market in September 2002.

#Biotechnology

Acquired by Takeda Pharmaceutical Company in February 2005.

#Biotechnology

Acquired by Cephalon, Inc. in May 2005.

#Biotechnology

Listed on the Tokyo Stock Exchange Mothers market in June 2006.

#Biotechnology

Underwent a management buyout in June 2007.

#Medical Devices

Listed on the JASDAQ NEO market in December 2007.

#Biotechnology


Key People

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.